Pap Smear Liquid-Based Cytology (LBC) is a cervical screening test that examines cells collected from the cervix for abnormal changes, including precancerous lesions and cervical cancer. In this method, collected cells are placed in a preservative solution and processed to create a cleaner, more uniform sample for microscopic evaluation. The test is needed for early detection of cervical abnormalities, enabling timely follow-up and treatment when required.
Screening intervals depend on age, HPV status, previous results, and applicable screening guidelines. Follow the schedule recommended by your healthcare provider.
LBC offers advantages such as more uniform sample preparation and reduced obscuring material in some specimens. The choice of screening method depends on available technology and local clinical guidelines.
If there are insufficient cells or the sample cannot be evaluated properly, the result may be reported as unsatisfactory. A repeat sample may then be recommended.
The examination may show certain cellular changes associated with inflammation or some infections, but LBC is not a comprehensive test for sexually transmitted or vaginal infections.
LBC can identify various cervical cell abnormalities, ranging from minor changes to high-grade precancerous lesions and, in some cases, findings suspicious for cancer.